Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):323-4. doi: 10.1159/000237015.

Abstract

Based on in vitro findings with mouse mast cells and in vivo findings in mice, we report that dexamethasone or cyclosporin A can have at least three actions which interfere with the pathogenesis IgE-, mast-cell-, and cytokine-dependent inflammatory reactions: suppression of the IgE-dependent increase in tumor necrosis factor (TNF)-alpha mRNA by mast cells, inhibition of the IgE-dependent production of TNF-alpha protein by mast cells, and diminution of the responsiveness of target cells to TNF-alpha. Our findings in mice raise the possibility that similar actions of these agents in humans may account for some of the clinical efficacy of corticosteroids and cyclosporin A in allergic diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Cyclosporine / pharmacology*
  • Dexamethasone / pharmacology*
  • Drug Synergism
  • Immunoglobulin E / immunology
  • Leukocytes / drug effects*
  • Leukocytes / metabolism
  • Mast Cells / drug effects*
  • Mast Cells / metabolism
  • Mice
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Tumor Necrosis Factor-alpha
  • Immunoglobulin E
  • Dexamethasone
  • Cyclosporine